Slichter S J, Deeg H J, Kennedy M S
Blood. 1987 Feb;69(2):414-8.
To study the immunosuppressive effects of three different treatments, 30 dogs received at weekly intervals eight platelet transfusions from a single random donor dog. The three experimental protocols were daily oral cyclosporine (Cs) treatment of recipients; in vitro ultraviolet (UV)-irradiation of donor platelets; and Cs-loading of donor platelets. All nine recipients of Cs, 11/12 (92%) recipients of UV-irradiated platelets, and 5/9 (56%) recipients of Cs-loaded donor platelets remained nonimmunized to repeated transfusions of donor platelets. In contrast, only 3 of 21 untreated controls (14%) were not alloimmunized by donor platelets. Moreover, 44% to 67% of the nonimmunized recipients remained tolerant to continued platelet transfusions from their original donor even after experimental therapy was discontinued. Forty-three percent to 100% of transfusions from secondary donors were also accepted without causing alloimmunization, suggesting that tolerance induced by prior treatment was not specific for the primary donor. However, survival of both the original and secondary donor platelets was reduced to about half the starting level, suggesting that some immune response to platelets had occurred. Also, recipients immunized by their original donor's platelets frequently developed refractoriness to platelets from other donors.
为研究三种不同治疗方法的免疫抑制作用,30只犬每周接受来自一只随机供体犬的8次血小板输注。三种实验方案分别是:对受体进行每日口服环孢素(Cs)治疗;对供体血小板进行体外紫外线(UV)照射;以及对供体血小板进行Cs负载。所有9只接受Cs治疗的受体、11/12(92%)接受紫外线照射血小板的受体以及5/9(56%)接受Cs负载供体血小板的受体,对供体血小板的重复输注仍未产生免疫。相比之下,21只未治疗的对照犬中只有3只(14%)未被供体血小板诱导产生同种免疫。此外,44%至67%的未产生免疫的受体即使在实验治疗停止后,仍对来自其原始供体的持续血小板输注保持耐受。来自二级供体的43%至100%的输血也被接受,且未引起同种免疫,这表明先前治疗诱导的耐受并非针对主要供体具有特异性。然而,原始供体和二级供体血小板的存活均降至起始水平的约一半,这表明对血小板发生了某种免疫反应。此外,被其原始供体血小板免疫的受体经常对来自其他供体的血小板产生难治性。